- Home
- JFBR vs APVO Comparison
JFBR vs APVO Comparison
Compare JFBR & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JFBR
- APVO
- Stock Information
- Founded
- JFBR 2017
- APVO 2016
- Country
- JFBR Israel
- APVO United States
- Employees
- JFBR N/A
- APVO N/A
- Industry
- JFBR Other Specialty Stores
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- JFBR Consumer Discretionary
- APVO Health Care
- Exchange
- JFBR Nasdaq
- APVO Nasdaq
- Market Cap
- JFBR 3.6M
- APVO 3.3M
- IPO Year
- JFBR 2022
- APVO N/A
- Fundamental
- Price
- JFBR $0.79
- APVO $0.67
- Analyst Decision
- JFBR
- APVO Strong Buy
- Analyst Count
- JFBR 0
- APVO 1
- Target Price
- JFBR N/A
- APVO $296.00
- AVG Volume (30 Days)
- JFBR 138.8K
- APVO 8.7M
- Earning Date
- JFBR 05-06-2025
- APVO 05-07-2025
- Dividend Yield
- JFBR N/A
- APVO N/A
- EPS Growth
- JFBR N/A
- APVO N/A
- EPS
- JFBR N/A
- APVO N/A
- Revenue
- JFBR $13,688,000.00
- APVO N/A
- Revenue This Year
- JFBR N/A
- APVO N/A
- Revenue Next Year
- JFBR N/A
- APVO N/A
- P/E Ratio
- JFBR N/A
- APVO N/A
- Revenue Growth
- JFBR 36.77
- APVO N/A
- 52 Week Low
- JFBR $0.17
- APVO $0.60
- 52 Week High
- JFBR $3.96
- APVO $51.06
- Technical
- Relative Strength Index (RSI)
- JFBR 27.29
- APVO 30.50
- Support Level
- JFBR $0.72
- APVO $0.60
- Resistance Level
- JFBR $1.01
- APVO $0.80
- Average True Range (ATR)
- JFBR 0.08
- APVO 0.18
- MACD
- JFBR -0.00
- APVO 0.03
- Stochastic Oscillator
- JFBR 21.35
- APVO 5.52
About JFBR Jeffs' Brands Ltd
Jeffs Brands Ltd is an e-commerce CPG company, operating on Amazon. The company serves as the holding company of other e-commerce companies, Smart Repair Pro, Purex, and Top Rank, that operate online stores for the sale of various consumer products on Amazon online marketplace, utilizing the FBA model. The company has five wholly-owned subsidiaries: Smart Repair Pro, Purex, Top Rank , Fort and Jeffs' Brands Holdings. The company also utilizes internal methodologies to analyze sales data and patterns on Amazon in order to identify existing stores, niches and products that have the potential for development and growth, and for maximizing sales of existing proprietary products.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.